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ABSTRACT 
Objective: Manilkara hexandra Roxb. (Family: Sapotaceae) is a common evergreen tree and commercial crop in India which is widely used as 
antibacterial, diuretic, anthelmintic, antioxidant and antidiabetic in folklore medicine in India. The objective of the study was to evaluate the 
antidiabetic activity of Manilkara hexandra bark in streptozotocin-induced diabetes in experimental animals. 
Methods: Non-insulin-dependent diabetes mellitus (NIDDM) was induced in overnight fasted rats by an intra-peritoneal injection (i. p.) of 60 mg/kg 
streptozotocin. 50 % ethanolic extract of M. hexandra, 250 mg/kg or 500 mg/kg body weight was administered orally to the rats once daily for 21 d. 
The blood glucose level was assessed by a glucometer. The serum levels of cholesterol, triglycerides, high-density lipoprotein (HDL) cholesterol and 
low-density lipoprotein (LDL) cholesterol were determined by using diagnostic kits.  
Results: A significant reduction (p<0.001) in the blood glucose level was observed in diabetic animals treated with the different doses of the extract, 
compared to untreated diabetic rats. The drug posses good hypolipidemic effect by normalizing the lipid parameters. This also evidenced by 
histopathological examination of isolated organs viz. pancreas and kidney showing reduced the injuries induced by streptozotocin.  
Conclusion: The result of this study thus shows that 50 % of the ethanolic extract at different doses possesses significant antidiabetic activity and 
potent hypolipidemic potential in diabetic conditions. 
Keywords: Antidiabetic, Bark extract, Histopathology, Manilkara hexandra, Streptozotocin 
© 2016 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/) 
 
INTRODUCTION 
Diabetes mellitus is linked with prejudice glucose metabolism that 
escorts to a rise in free radical production and augmentation in the 
lipoprotein and triglyceride levels. The purported Indian Phenotype 
proposed to have inimitable biochemical as well as a clinical 
idiosyncrasy in the Indians of Asia. This assemblage of abnormalities 
is well thought-out to be one of the foremost factors contributing to 
raising pervasiveness of type 2 diabetes in Indians of Asia. The 
ultimate goal of diabetes therapy is to prevent micro-and 
macrovascular complications in order to improve life expectancy 
and quality of life [1]. The general consensus on treatment of type 2 
diabetes is that lifestyle management is at the forefront of therapy 
options. In addition to exercise, weight control, and medical 
nutrition therapy, oral glucose-lowering drugs and injections of 
insulin are the conventional therapies. Since the most important 
pathological process during the development of diabetes involves 
three key organs, i.e., pancreatic islets, liver, and skeletal muscle, 
almost all anti-diabetic therapies are aimed at these organs. 
 Experimental diabetes in animals has endowed with an extensive 
approach into the physiologic and biochemical clutter of the diabetic 
state. In recent years, the plants provide a potential source of 
hypoglycemic drugs because many plants and plant-derived 
compounds have been used in the treatment of diabetes. The use of 
plants as a source of drugs and their validation is gaining increasing 
attention [2]. Because of this bleak forecast, research on anti-
diabetic plants has been strongly encouraged by World Health 
Organization. Manilkara hexandra (Roxb.) Dubard is a large 
evergreen tree widely distributed throughout the greater parts of 
India and other tropical countries. The stem bark is astringent, 
febrifuge, sweet, tonic, and is used traditionally to treat a wide range 
of gastrointestinal symptoms.[3]Previously isolated constituents of 
the plant are Saponins, cinnamic acid, hentriacontane, taraxerol, 
quercitol, gallic acid, hexandrone, hexandrin, taraxerol, quercetin, 
quercitrin and beta-sitosterol [4, 5]. Although decoction of M. 
hexandra bark has been used to treat diabetes as a folk medicine, no 
scientific report exists for the use of this plant to treat diabetes. 
Therefore an attempt has been made for investigating its 
antihyperglycemic activity and effects on total lipid, cholesterol, and 
triglycerides as scientific evidence. 
MATERIALS AND METHODS 
Plant material 
Fresh bark was stripped from the trunk of fully-grown tree 
Manilkara hexandra (Roxb.) Dubard (Sapotaceae) from BSI campus, 
Allahabad and authenticated by a taxonomist Dr. A S Sandhu, of 
National Institute of Pharmaceutical Education & Research (NIPER), 
Mohali with voucher specimen number NIP-NPM-CD-157. 
Extract preparation 
The freshly collected bark (2 kg) of M. hexandra were first air-dried 
and then dried in tray drier under control conditions and powdered. 
The powdered bark (1 kg) was macerated with petroleum ether to 
remove fatty substances; the marc was further exhaustively 
extracted with of ethanol (50 % v/v) for 72 h by cold percolation 
method. The extract was separated by filtration and concentrated on 
rotavapour (Buchi, USA) and then dried in lyophilizer (Labconco, 
USA) under reduced pressure, and thus, 120.0 g of solid residue 
(yield 12 % w/w) was obtained. 
Phytochemical screening 
Phytochemical screening of extract was carried out by standard 
procedures [6], which revealed the presence of chemical 
constituents like fixed oil, flavonoids, phenolic compounds 
phytosterol and saponins.  
Experimental animals 
Healthy adult Wistar albino rats weighing 200–250 g were used for 
the pharmacological studies. These animals were kept in 
polypropylene cages for a minimum of 5 d prior to oral administration 
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at the Girijananda Chowdhury Institute of Pharmaceutical Science 
(GIPS), Azara, Guwahati animal room to allow for their acclimatization 
to the laboratory conditions. The animal room was ventilated with 12-
h cycle of day and night light conditions, and the temperature 
maintained at approximately 25 ˚C. They were fed with standard rat 
pellet diet (Amrut, India) and water ad libitum. The protocol for this 
study was approved by the Girijananda Chowdhury Institute of 
Pharmaceutical Science Institutional Animal Ethical Committee (No. 
GIPS/IAEC/2012/06) Guwahati.  
Oral acute toxicity study 
The median lethal dose (LD50
Treatment of experimental animals with plant extracts was initiated 
2 d post streptozotocin injection and was carried out once daily, by 
gavage, for 21 d. Food and water were made freely available. The 
blood glucose level was determined by glucometer (Sugar scan). The 
values of the sample treated were compared with that of the 
standard group which was treated with Glibenclamide. After the 
experimental regimen, the animals were sacrificed by cervical 
dislocation under mild ether anesthesia. The kidney and pancreas 
were exposed and perfused with cold saline phosphate buffer of pH 
7.4 for histopathological examination. The collected blood samples 
were immediately centrifuged at 3000 rpm for 10 min. The serum 
separated was collected in fresh serum tubes and stored in the 
refrigerator (2-4
) determination was done in rats by 
OECD guidelines 423 [7]. A single dose of the extracts (5 mg/kg, 50 
mg/kg, 300 mg/kg and 2000 mg/kg) in an appropriate quantity of 
water was given orally by gavage to a different group of animals 
(three each). The animals were allowed free access to water and 
food. However, all the animals were deprived of food for 2 hr before 
and 4 hr after dosing. Each animal was observed each time for the 
first 5 min after loading for signs of regurgitation and then kept in 
individual polypropylene rat cage. Each animal was observed for 
every 15 min in the first 4 h after dosing, then every 30 min for the 
successive 6 h and then daily for the successive 48 h for the short-
term outcome and the remaining 14 d for the long-term possible 
lethal outcome. 
Experimental induction of diabetes 
Streptozotocin (STZ) was freshly dissolved in (0.1M, pH 4.5) citrate 
buffer and maintained on ice prior to use. Non-insulin-dependent 
diabetes mellitus was induced in overnight fasted rats by a single 
intraperitoneal injection of Streptozotocin (60 mg/kg b. w), all 
animals were given free access to food and water. Blood glucose levels 
were measured 2 d after STZ injection and used as parameters to 
obtain matching pairs of rats with diabetes of similar level of severity. 
Only rats with fasting blood glucose levels greater than 220 mg/dl 
were considered to be diabetic and were used in the experiment. The 
animals were randomly assigned to five different groups i.e. group I to 
V. Group I served as a control containing 6 normal rats [8]. 
Experimental design 
Five groups of rats were used to study the effect of 50 % ethanolic 
extract of M. hexandra. Each group consisting of six rats. 
Group I-Control rats received vehicle normal saline solution 
Group II-Diabetic control rats received vehicle normal saline 
solution 
Group III and IV-Diabetic rats treated with extract 250 & 500 mg/kg 
body weight respectively. 
Group V-Diabetic rats treated with standard drug Glibenclamide 600 
µg/kg body weight  
˚
Histopathological examination 
C) after tightly capped. The total serum Cholesterol, 
Triglyceride, and lipid concentrations were determined using 
commercial kits by enzymatic photocolorimetry methods [9]. 
At the end of the treatment period the control, as well as treated 
rats, were sacrificed by using cervical dislocation and the organs viz. 
pancreas and kidney were dissected out and immediately fixed in 
bouin’s fluid for 24 hr and washed in running tap water to remove 
the colour of bouin’s fluid and dehydrated in alcohol in ascending 
and descending order, embedded in paraffin and cut at 5μm in a 
rotary microtome. These sections were then deparaffinized in xylene 
and stained with hematoxylin-eosin and mounted with canada 
balsam. The histopathological slides were examined, and 
photographs were captured with a digital stereomicroscope 
(Olympus, B061) [10]. 
Statistical analysis 
The statistical analysis of all the pharmacological analysis was 
carried out using GraphPad Prism version 3.03 for windows. The 
values are represented as mean±SD. for six rats data were analyzed 
by ANOVA with post-hoc difference was analyzed using Newman-
keuls method. 
RESULTS 
Acute toxicity study 
In acute toxicity study, extract treated animals did not show any 
change in their behavioral pattern. There was no significant difference 
in the body weights and food consumption when compared to the 
vehicle-treated group. Also, no gross pathological changes were seen. 
Thus, it was concluded that aqueous alcoholic extract of M. hexandra 
was safe at 2000 mg/kg. On the basis of toxicity study, two doses i.e. 
250 and 500 mg/kg were selected for antidiabetic activity. 
Antihyperglycemic activity 
There was a significant elevation in serum glucose, total cholesterol, 
triglycerides and lipid in the diabetic control group animals. Table 1 
shows the effect of the daily oral administration of 50 % ethanolic 
extract (250 mg/kg and 500 mg/kg) on the blood glucose level in 21 
d. By the end of treatment, the blood glucose level reduced from 
245.33 mg/dL to 124.33 mg/dL in rats treated at a dose of 250 
mg/kg (p<0.01). For the oral administration of 500 mg/kg of the 
extract, the blood glucose level reduced from 248.16 mg/dL to 85.00 
mg/dL at 21 d (p<0.001). For glibenclamide (600 µg/kg), the blood 
glucose level reduced from 241.16 mg/dL to 85.83 mg/dL 
(p<0.001). Table 2 shows the levels of biochemical parameters such 
as the levels of total cholesterol, triglycerides, and total lipids. MHE 
at the dose of 250 mg/kg & 500 mg/kg decreasing the cholesterol 
(82.59±5.06 & 76.11±5.53 mg/dl respectively as compared to 
diabetic control group (136.51±5.85 mg/dl) (p<0.001) and 
triglycerides level (96.20±5.01 & 82.88±3.72 mg/dl as compared to 
diabetic control group (154.81±3.83) (p<0.001). MHE also showed 
significantly (p<0.001) effect on HDL and LDL level. By contrast, the 
50 % ethanolic extract of M. hexandra bark in the groups treated at a 
dose of 250 mg/kg or 500 mg/kg once daily for 21 d prevented the 
diabetic condition in a dose-related manner. 
  
Table 1: Effect of 50 % ethanolic extract of M. hexandra on serum glucose level in STZ induced diabetic rats 
Groups Treatment/Dose 0 d (mg/dl) After 7 d (mg/dl) After 14 d (mg/dl) After 21 d (mg/dl) 
I Normal control 76.16±4.74 76.83±4.17 76.33±5.02 74.50±3.09 
II Diabetic control  246.33±6.62 234.33±10.99**** 200.33±4.81**** 235.66±4.95**** 
III 
**** 
MHE (250 mg/kg)  245.33±4.60 230.33±7.49 185.66±5.93 124.33±4.57* 
IV 
** 
MHE (500 mg/kg) 248.16±4.29 219.16±8.27 184.16±10.12 85.00±5.32** 
V 
*** 
Glibenclamide (600µg/kg) 241.16±8.83 210.66±10.59 180.83±8.98 85.83±8.93*** 
The value represents the means±S. D. for 6 rats per group. *p<0.05, **p<0.01 and ***p<0.001 compared to diabetic control group. ****p<0.001 as 
compared to the normal group.  
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Table 2: Effect of 50 % ethanolic extract of M. hexandra stems bark on TG, Cholesterol, HDL and LDL in STZ induced diabetic rats 
Groups Treatment/Dose Triglyceride 
(mg/dl) 






I Normal control  71.03±2.92 74.69±4.72 39.45±3.97 20.16±2.52 
II Diabetic control  154.8±3.83 136.51±5.85**** 25.08±3.40**** 33.31±3.98**** 
III 
**** 
MHE (250 mg/kg) 96.2±5.01 82.59±5.06*** 35.47±4.93*** 19.50±1.63*** 
IV 
*** 
MHE (500 mg/kg) 82.88±3.72 76.11±5.53*** 45.33±4.71*** 12.74±3.74*** 
V 
*** 
Glibenclamide (600µg/kg) 75.35±3.27 84.98±5.41*** 34.35±5.47*** 24.14±2.15*** *** 
The value represents the means±SD. for 6 rats per group. ***p<0.001 compared to diabetic control group. ****
 
p<0.001 as compared to normal group. 
Histopathological investigation 
Pancreas 
Microscopically examined pancreas section of the control group (1A) 
showed Islets are normal. The architecture is preserved. The acini 
are lined by round to oval cells with moderate cytoplasm and small 
round to oval nuclei.  
Microscopically examined pancreas section of the diabetic control 
group (1B) showed Islets with depletion of cells. The architecture is 
preserved. The acini lined by round to oval cells with moderate 
cytoplasm and small round to oval nuclei. 
Microscopically examined pancreas section of 50 % ethanolic extract 
of the bark of M. hexandra treated group 250 mg/kg (1C) showed 
the architecture is partially effaced. The islets are normal. The acinar 
cells are normal. There is a mild and diffuse infiltrate of lymphocytes 
within the stroma.  
Microscopically examined pancreas section of 50 % ethanolic extract 
of the bark of M. hexandra treated group 500 mg/kg (1D) showed 
the architecture is normal. The islets show depletion of the acinar 
cell. The acinar cells show moderate cytoplasm and round to oval 
nuclei. There is no evidence of inflammation. 
 
 
Fig. 1: Histopathology of pancreas 
 
The normal architecture was restored to the same as that of the 
standard drug (Glibenclamide) treated pancreas (1E). 
Kidney 
Microscopically examined kidney section of the control group (2A) 
showed the glomeruli appear and tubules are normal and lined by a 
single layer of cuboidal cells.  
Microscopically examined kidney section of the diabetic control 
group (2B) revealed the glomeruli show normal mesangial 
hypercellularity and focal glomerulosclerosis. The stroma shows a 
diffuse infiltrate of lymphocytes. 
Microscopically examined kidney section of 50 % ethanolic extract 
of the bark of M. hexandra at a dose of 250 and 500 mg/kg treated 
group (2C & 2D) illustrate that the glomeruli show mesangial 
hypercellularity. The tubules are normal. The stroma is normal. 
The normal architecture was restored to the same as that of the 
standard drug (Glibenclamide) treated kidney (2E). which revealed 
that glomeruli appear normal. The tubules are normal and lined by a 
single layer of cuboidal cells. The stroma is normal. This is evident 




Fig. 2: Histopathology of kidney 
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DISCUSSION 
Streptozotocin-induced diabetes in rats appears to be the most 
suitable animal model because it reflects the symptoms of diabetes 
in human. The elevated blood glucose levels in diabetes are thought 
to lead to cell death through oxidative stress induction that occurs as 
a common sequel of diabetes-induced modification of sugar moieties 
on proteins and lipids [11]. Hyperglycemia increases oxidative 
stress through the overproduction of reactive oxygen species, which 
results in an imbalance between free radicals and the antioxidant 
defense systems of the cells. In the present study, 50 % ethanolic 
extract of bark of Manilkara hexandra (MHE) at different doses (250 
and 500 mg/kg body weight) showed a marked antihyperglycemic 
and hypolipidemic effects which could be attributed to the 
potentiation of the insulin effect of plasma by increasing the 
pancreatic secretion of insulin from existing β-cells or their radical 
scavenging activities. Diabetes is also known to be associated with 
an increase in the synthesis of cholesterol, which may be due to the 
increased activity of HMG-CoA reductase. A number of observations 
indicate that plasma high-density lipoprotein (HDL) cholesterol is 
low in untreated insulin-deficient diabetics, [12, 13] which was 
associated with a decline in HDL-turnover rate. Further, the HDL-
cholesterol levels correlate with lipoprotein lipase (LPL) levels in 
IDDM patients [14]. Increased LDL-cholesterol may arise from 
glycosylation of the lysyl residues of apoprotein B as well as from 
decreasing affinity for the low-density lipoprotein (LDL) receptor 
and hence, decreased metabolism [15]. The ability of LDL-
cholesterol to form lipid peroxides was found specifically 
responsible for the atherogenesis in diabetic patients.[16] Bruan and 
Severson (1992) have reported that deficiency of lipoprotein lipase 
(LPL) activity may contribute significantly to the elevation of 
triglycerides in diabetes. The elevated serum phospholipid levels are 
a consequence of elevated lipoproteins [17]. Our investigations 
indicate the efficiency of the extract in the maintenance of blood 
glucose levels in streptozotocin-induced diabetic rats. 
Administration of aqueous ethanolic extract of M. hexandra to 
diabetic rats showed a significant reduction in the levels of blood 
glucose. The possible mechanism by which 50 % ethanolic extract 
brings about its hypoglycemic action in diabetic rats may be by 
potentiating the insulin effect of plasma by increasing either the 
pancreatic secretion of insulin from the existing beta cells or by its 
release from the bound form due to the presence of flavonoids in the 
bark extract. The investigations also indicate that oral 
administration of plant extracts normalized these effects, possibly 
by controlling the hydrolysis of certain lipoproteins and their 
selective uptake and metabolism by different tissues. Thus, it may be 
concluded plant extracts may have a stimulatory effect on insulin. 
The restoration of phospholipids by plant extract may be controlled 
mobilization of serum triglycerides; controlling the tissue 
metabolism and improving the level of insulin secretion and action 
presumably mediate cholesterol and phospholipids. This is also 
evidenced by histopathological examination of isolated organs 
showing reduced the injuries induced by streptozotocin. 
CONCLUSION 
The present study provided evidence indicating that 50 % ethanolic 
extract of M. hexandra bark significantly reduces the levels of 
glucose in diabetic rats. In addition, treatment with the extract 
causes the recovery of certain altered biochemical parameters of 
diabetic animals. This being so, these results validates the traditional 
use of the plant in the treatment of diabetes.  
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